The immunology of COVID-19: is immune modulation an option for treatment?
Top Cited Papers
- 1 July 2020
- journal article
- review article
- Published by Elsevier BV in The Lancet Rheumatology
- Vol. 2 (7), e428-e436
- https://doi.org/10.1016/s2665-9913(20)30120-x
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81974254, 81670431, 81771754)
- Tongji Hospital Clinical Research Flagship Program (2019CR206)
This publication has 98 references indexed in Scilit:
- Conversion From Tacrolimus/Mycophenolic Acid to Tacrolimus/Leflunomide to Treat Cutaneous Warts in a Series of Four Pediatric Renal Allograft RecipientsTransplantation, 2012
- Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and DeltacoronavirusJournal of Virology, 2012
- Leflunomide for cytomegalovirus: bench to bedsideTransplant Infectious Disease, 2011
- Predictors of major infections in systemic lupus erythematosusArthritis Research & Therapy, 2009
- Higher Levels of Leflunomide Are Associated with Hemolysis and Are not Superior to Lower Levels for BK Virus Clearance in Renal Transplant PatientsClinical Journal of the American Society of Nephrology, 2008
- Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging InfectionClinical Microbiology Reviews, 2007
- Review of Bats and SARSEmerging Infectious Diseases, 2006
- Bats Are Natural Reservoirs of SARS-Like CoronavirusesScience, 2005
- Chloroqine Treatment of Severe Malaria in ChildrenThe New England Journal of Medicine, 1988
- Parenteral Chloroquine for Treating Falciparum MalariaThe Journal of Infectious Diseases, 1987